Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT) | Annals of Surgery | 2019 | 186 |
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer | Annals of Oncology | 2019 | 120 |
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea | Journal of Hepatology | 2019 | 91 |
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study | Lancet, The | 2019 | 90 |
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons | Annals of Surgery | 2019 | 82 |
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial | Journal of Hepatology | 2019 | 81 |
2018 Guidelines for the management of dyslipidemia | Korean Journal of Internal Medicine | 2019 | 79 |
Prediction of Postoperative Pulmonary Complications Using Preoperative Controlling Nutritional Status (CONUT) Score in Patient with Resectable Non-small Cell Lung Cancer (P12-032-19) | Current Developments in Nutrition | 2019 | 78 |
SUN-134 The Frequency of Type 1 Diabetes among Adolescent Patients with Moyamoya Disease | Journal of the Endocrine Society | 2019 | 78 |
MON-548 The Relationship of Comorbidities to Mortality and Cause of Death in Patients with Differentiated Thyroid Carcinoma | Journal of the Endocrine Society | 2019 | 78 |
SAT-278 Changes in Biochemical and Electrocardiographic Findings During Insulin Tolerance Test | Journal of the Endocrine Society | 2019 | 78 |
MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal | Journal of the Endocrine Society | 2019 | 78 |
EXTH-23. COMBINED EFFECTS OF NICLOSAMIDE AND TEMOZOLOMIDE AGAINST HUMAN GLIOBLASTOMA TUMORSPHERES | Neuro-Oncology | 2019 | 78 |
GEN-13 FIREWORK PATTERN OF CANCER GENESIS FOR GLIOBLASTOMA, IDH-WILDTYPE | Neuro-Oncology Advances | 2019 | 78 |
Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma | Clinical Cancer Research | 2019 | 77 |
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer | Future Oncology | 2019 | 77 |
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105 | Cancer Discovery | 2019 | 67 |
Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018 | Radiology | 2019 | 54 |
Adipose-Derived Mesenchymal Stem Cells Promote M2 Macrophage Phenotype through Exosomes | Stem Cells International | 2019 | 54 |
Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology | Korean Journal of Radiology | 2019 | 49 |
Clinicopathologic and Molecular Characteristics of Mesonephric Adenocarcinoma Arising From the Uterine Body | American Journal of Surgical Pathology | 2019 | 49 |
Lessons Learned From GWAS of Asthma | Allergy, Asthma and Immunology Research | 2019 | 46 |
Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer | Clinical Lung Cancer | 2019 | 43 |
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA | Clinical Epigenetics | 2019 | 42 |
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma | Oncologist | 2019 | 41 |